124 related articles for article (PubMed ID: 11917576)
1. Validation of AutoPap primary screening system sensitivity and high-risk performance.
Tench WD
Acta Cytol; 2002; 46(2):296-302. PubMed ID: 11917576
[TBL] [Abstract][Full Text] [Related]
2. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ; Dax Taylor D
Cancer; 1999 Dec; 87(6):354-8. PubMed ID: 10603189
[TBL] [Abstract][Full Text] [Related]
3. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
[TBL] [Abstract][Full Text] [Related]
4. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity studies of AutoPap System Location-Guided Screening of cervical-vaginal cytologic smears.
Huang TW; Lin TS; Lee JS
Acta Cytol; 1999; 43(3):363-8. PubMed ID: 10349363
[TBL] [Abstract][Full Text] [Related]
6. A feasibility study of the AutoPap system location-guided screening.
Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
[TBL] [Abstract][Full Text] [Related]
7. Performance of the AutoPap Primary Screening System in the detection of high-risk cases in cervicovaginal smears.
Alasio LM; Alphandery C; Grassi P; Ruggeri M; De Palo G; Pilotti S
Acta Cytol; 2001; 45(5):704-8. PubMed ID: 11575647
[TBL] [Abstract][Full Text] [Related]
8. Atypical endocervical glandular cells: accuracy of cytologic diagnosis.
Lee KR; Manna EA; St John T
Diagn Cytopathol; 1995 Oct; 13(3):202-8. PubMed ID: 8575278
[TBL] [Abstract][Full Text] [Related]
9. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
[TBL] [Abstract][Full Text] [Related]
10. A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device.
Confortini M; Bonardi L; Bulgaresi P; Cariaggi MP; Cecchini S; Ciatto S; Cipparrone I; Galanti L; Maddau C; Matucci M; Rubeca T; Troni GM; Turco P; Zappa M; Carozzi F
Cancer; 2003 Jun; 99(3):129-34. PubMed ID: 12811852
[TBL] [Abstract][Full Text] [Related]
11. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion.
Nasser SM; Cibas ES; Crum CP; Faquin WC
Cancer; 2003 Oct; 99(5):272-6. PubMed ID: 14579293
[TBL] [Abstract][Full Text] [Related]
12. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
Bibbo M; Hawthorne C; Zimmerman B
Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
[TBL] [Abstract][Full Text] [Related]
13. Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
Ge Y; Christensen P; Luna E; Armylagos D; Schwartz MR; Mody DR
Cancer Cytopathol; 2017 Aug; 125(8):652-657. PubMed ID: 28574670
[TBL] [Abstract][Full Text] [Related]
14. The primary screening clinical trials of the TriPath AutoPap System.
Wilbur DC; Norton MK
Epidemiology; 2002 May; 13 Suppl 3():S30-3. PubMed ID: 12071481
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma in situ of the cervix.
Schoolland M; Segal A; Allpress S; Miranda A; Frost FA; Sterrett GF
Cancer; 2002 Dec; 96(6):330-7. PubMed ID: 12478680
[TBL] [Abstract][Full Text] [Related]
16. Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature.
Ince U; Aydin O; Peker O
Gynecol Oncol; 2011 Apr; 121(1):152-6. PubMed ID: 21211831
[TBL] [Abstract][Full Text] [Related]
17. Comparative sensitivities of ThinPrep and Papanicolaou smear for adenocarcinoma in situ (AIS) and combined AIS/high-grade squamous intraepithelial lesion (HSIL): comparison with HSIL.
Roberts JM; Thurloe JK
Cancer; 2007 Dec; 111(6):482-6. PubMed ID: 17969065
[TBL] [Abstract][Full Text] [Related]
18. Cytologic features of high grade squamous intraepithelial lesions involving endocervical glands on thin-layer cytology.
Selvaggi SM
Acta Cytol; 2005; 49(6):689-90. PubMed ID: 16450913
[No Abstract] [Full Text] [Related]
19. Whole-Slide Imaging of Pap Cellblock Preparations Is a Potentially Valid Screening Method.
Tawfik O; Davis M; Dillon S; Tawfik L; Diaz FJ; Amin K; Fan F
Acta Cytol; 2015; 59(2):187-200. PubMed ID: 25967603
[TBL] [Abstract][Full Text] [Related]
20. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
Marshall CJ; Rowe L; Bentz JS
Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]